Poseida Therapeutics Inc.

Poseida Therapeutics Inc.

World Rank (Jan-05-2024)
15,594
Market Cap (Jan-05-2024)
0.308 Billion USD
World Rank (Jul-30-2023)
19,594
Market Cap (Jul-30-2023)
0.149 Billion USD
World Rank (Jan-07-2022)
14,871
Market Cap (Jan-07-2022)
0.399 Billion USD
World Rank (Jan-01-2021)
9,697
Market Cap (Jan-01-2021)
0.678 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PSTX
Employee Count
263
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-130 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
POSEIDA THERAPEUTICS, INC.
Company Profile
Poseida Therapeutics is a Clinical Stage Biopharmaceutical company focused on gene engineering platform technologies and better treatments to patients with serious diseases with blood cancers like multiple myeloma, solid tumor cancers like prostate and breast cancer, and rare genetic diseases in the liver. The company estimated annual revenue is currently 32.6 million USD per year. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share